Skip to main content
. 2013 Mar 1;2(1):21–23. doi: 10.1002/cld.161

Table 2.

Definitions for NUC Treatment Failure

Primary nonresponse <1 log10 IU/mL decrease in HBV DNA level at 12 weeks of therapy compared with baseline
Partial virological response Detectable levels of HBV DNA after 24 weeks (LMV, LdT, ADV) or 48 weeks (ETV, TDF) of therapy in a compliant patient
Virological breakthrough Confirmed increase in HBV DNA level of >1 log10 IU/mL compared with the lowest HBV DNA level on therapy (nadir)